One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Alcohol and health: all, none, or somewhere in-between?
doi : 10.1016/S2665-9913(23)00073-5
Volume 5, Issue 4, April 2023, Page e167
Immunoglobulin, glucocorticoid, or combined therapy for multisystem inflammatory syndrome in children
doi : 10.1016/S2665-9913(23)00035-8
Volume 5, Issue 4, April 2023, Pages e168-e169
Prevention of psoriatic arthritis: the next frontier
Alexis Ogdie a, Jose U Scher b c d
Assessment of treatment efficacy in polymyalgia rheumatica
Suzanne Arends a, Kornelis SM van der Geest a, Maria Sandovici a
Methotrexate in rheumatoid arthritis—another brick in the wall
Andrea Rubbert-Roth a
Giant cell arteritis can occur in people of colour
Tiara Gill a, Michael Putman b, Sebastian E Sattui c, Shahir Hamdulay a, Richard Conway d, David F L Liew e f, Aman Sharma g, John H Stone h, Sarah L Mackie i j, Puja Mehta k l
Thank you to our contributors and peer reviewers in 2022
doi : 10.1016/S2665-9913(23)00058-9
Volume 5, Issue 4, April 2023, Page e177
Thank you to The Lancet Rheumatology's peer reviewers in 2022
doi : 10.1016/S2665-9913(23)00057-7
Volume 5, Issue 4, April 2023, Pages e177-e179
Patient-led research in rheumatology: the way forward?
doi : 10.1016/S2665-9913(23)00061-9
Volume 5, Issue 4, April 2023, Page e180
Patient–researcher co-presentation of research results to people living with systemic sclerosis
doi : 10.1016/S2665-9913(23)00063-2
Volume 5, Issue 4, April 2023, Pages e180-e181
Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study
doi : 10.1016/S2665-9913(23)00029-2
Volume 5, Issue 4, April 2023, Pages e184-e199
Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study
Shikha Singla MD a, Michael Putman MD a, Jean Liew MD c, Prof Kenneth Gordon MD b
1-year results of treatment with rituximab in polymyalgia rheumatica: an extension study of a randomised double-blind placebo-controlled trial
Thomas E Bolhuis MD a b, Diane E Marsman MD PhD a, Alfons A den Broeder MD PhD a c, Nathan den Broeder MSc a b, Aatke van der Maas MD PhD a
Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial
Hiroya Tamai MD a, Kei Ikeda PhD c, Toshiaki Miyamoto MD d, Hiroaki Taguchi PhD e, Prof Chang-Fu Kuo PhD f, Prof Kichul Shin PhD g, Prof Shintaro Hirata PhD h, Yutaka Okano PhD i, Prof Shinji Sato PhD j, Prof Hidekata Yasuoka PhD k, Prof Masataka Kuwana PhD l, Prof Tomonori Ishii PhD m, Prof Hideto Kameda PhD n, Toshihisa Kojima PhD o p, Takehiro Taninaga BS r, Masahiko Mori BS r, Hideaki Miyagishi MS s, Yasunori Sato PhD b, Prof Wen-Chan Tsai PhD q, Prof Tsutomu Takeuchi PhD a…Tien-Tsai Cheng
The influence of sex hormones on musculoskeletal pain and osteoarthritis
doi : 10.1016/S2665-9913(23)00060-7
Volume 5, Issue 4, April 2023, Pages e225-e238
